Suppr超能文献

血浆二肽基肽酶4(DPP4)活性升高可预测中国人群4年内新发高血压:可能与炎症和氧化应激有关。

Increased plasma DPP4 activity predicts new-onset hypertension in Chinese over a 4-year period: possible associations with inflammation and oxidative stress.

作者信息

Zheng T, Chen T, Liu Y, Gao Y, Tian H

机构信息

1] Department of Endocrinology and Metabolism, West China Hospital of Sichuan University, Sichuan, China [2] Department of Endocrinology and Metabolism, Affiliated Hospital of Guilin Medical University, Guangxi, China.

Department of Endocrinology and Metabolism, West China Hospital of Sichuan University, Sichuan, China.

出版信息

J Hum Hypertens. 2015 Jul;29(7):424-9. doi: 10.1038/jhh.2014.111. Epub 2014 Nov 20.

Abstract

To investigate whether increased dipeptidyl peptidase 4 (DPP4) activity predicts new-onset hypertension in Chinese patients. A prospective study was conducted for 1884 adults (804 men/1080 women) aged 18-70 years without hypertension. Participants were examined in 2007 (baseline) and 2011 (follow-up) and circulating DPP4 activity, mannose 6-phosphate receptor (M6P-R) concentration, inflammatory markers and oxidative stress parameters were measured. After a 4-year follow-up, 296 individuals developed hypertension with an incidence of 39 per 1000 patient years. In multiple linear regression analyses, baseline DPP4 activity was an independent predictor of an increase in M6P-R, inflammatory markers and oxidative stress parameters over a 4-year period (all P < 0.01). Cox proportional hazards models revealed that DPP4 activity independently predicted the risk of developing hypertension (relative risk 2.68 (95% confidence interval 1.71-4.21) P < 0.01). Our results indicate that DPP4 activity is an important predictor of hypertension onset in apparently healthy Chinese individuals. This finding may have important implications for understanding the effects of DPP4 in promoting inflammation and oxidative stress in the pathogenesis of hypertension.

摘要

为了研究二肽基肽酶4(DPP4)活性增加是否可预测中国患者新发高血压。对1884名年龄在18 - 70岁、无高血压的成年人(804名男性/1080名女性)进行了一项前瞻性研究。参与者于2007年(基线)和2011年(随访)接受检查,并检测循环DPP4活性、甘露糖6 - 磷酸受体(M6P - R)浓度、炎症标志物和氧化应激参数。经过4年随访,296人发生高血压,发病率为每1000患者年39例。在多元线性回归分析中,基线DPP4活性是4年内M6P - R、炎症标志物和氧化应激参数增加的独立预测因子(所有P < 0.01)。Cox比例风险模型显示,DPP4活性独立预测发生高血压的风险(相对风险2.68(95%置信区间1.71 - 4.21),P < 0.01)。我们的结果表明,DPP4活性是明显健康的中国个体高血压发病的重要预测因子。这一发现可能对理解DPP4在高血压发病机制中促进炎症和氧化应激的作用具有重要意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验